# FDA Inspection 1299118 - Lilly S.A. - February 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/lilly-sa/ed48391a-5144-45f7-925b-b054e182b38b
Source feed: FDA_Inspections

> FDA Inspection 1299118 for Lilly S.A. on February 14, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1299118
- Company Name: Lilly S.A.
- Inspection Date: 2024-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1204907 - 2021-03-09](https://www.keypedia.com/records/fda_inspections/lilly-sa/e06b5cf0-ae72-4142-8167-723735556cfe)
- [FDA Inspection 1118460 - 2018-03-15](https://www.keypedia.com/records/fda_inspections/lilly-sa/f38061be-5276-4a4c-906c-1cba45cc432e)
- [FDA Inspection 853424 - 2013-10-18](https://www.keypedia.com/records/fda_inspections/lilly-sa/788c40c6-c33b-4e8f-a709-196933c928d0)

Company: https://www.keypedia.com/companies/lilly-sa/71ddb2b3-2d8a-4c9a-850c-1c207c5f2c9f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c